Literature DB >> 6177409

Development and application of a radioimmunoassay for pepleomycin.

G W Aherne, N Saesow, S James, V Marks.   

Abstract

A rapid sensitive radioimmunoassay for pepleomycin (PM) has been developed using an antiserum produced in a sheep in response to a bovine serum albumin-drug conjugate. Radioiodinated PM was prepared using Iodogen. The assay was reproducible with a limit of detection in plasma of 200 ng/liter. The antiserum does not cross-react with bleomycin or with a number of unrelated drugs. Pharmacokinetic studies using the assay were carried out in three patients who received a short iv infusion of 5 mg/m2 of PM. The drug disappeared from the plasma with an elimination half-life of approximately 3 hours.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6177409

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


  1 in total

1.  Occurrence of an anti-peplomycin IgE antibody cross-reacting with bleomycin in a patient with cervical uterine cancer.

Authors:  H Sakura; T Fujii; T Ohashi; S Tsuruta
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.